How has been the historical performance of Artemis Medicare?

Oct 06 2025 10:48 PM IST
share
Share Via
Artemis Medicare has shown significant growth in net sales, increasing from 408.40 Cr in March 2021 to 936.92 Cr in March 2025, with profit after tax rising from 6.16 Cr to 82.18 Cr during the same period. The company has demonstrated robust financial performance with consistent growth in sales, profits, and total assets.
Answer:
The historical performance of Artemis Medicare shows significant growth in net sales and profitability over the years, culminating in the fiscal year ending March 2025. Breakdown: Artemis Medicare's net sales have steadily increased from 408.40 Cr in March 2021 to 936.92 Cr in March 2025, reflecting a strong upward trend. The total operating income followed a similar trajectory, rising from 554.80 Cr in March 2022 to 936.92 Cr in March 2025. Operating profit (PBDIT) also saw substantial growth, reaching 0.00 Cr in March 2025, up from 38.73 Cr in March 2021. Profit before tax improved to 0.00 Cr in March 2025, indicating a positive shift in financial performance. Profit after tax reached 82.18 Cr in March 2025, compared to just 6.16 Cr in March 2021, showcasing a remarkable increase in profitability. The company's total assets grew from 586.44 Cr in March 2020 to 1,357.41 Cr in March 2025, while total liabilities increased from 600.09 Cr to 1,357.41 Cr during the same period. Cash flow from operating activities improved significantly, reaching 145.00 Cr in March 2025, compared to 27.00 Cr in March 2021. Overall, Artemis Medicare has demonstrated a robust financial performance with consistent growth in sales, profits, and asset base over the years.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News